BREAKINGتازہ ترینताज़ा खबर
Anthropic's compute costs eat a bigger share of revenue as growth surgesAnthropic's compute costs eat a bigger share of revenue as growth surgesAnthropic's compute costs eat a bigger share of revenue as growth surgesStartup plans 50,000 space mirrors to beam sunlight down at nightStartup plans 50,000 space mirrors to beam sunlight down at nightStartup plans 50,000 space mirrors to beam sunlight down at nightChina steps up Middle East diplomacy as fears grow of a renewed US-Iran warChina steps up Middle East diplomacy as fears grow of a renewed US-Iran warChina steps up Middle East diplomacy as fears grow of a renewed US-Iran warTrump makes his last pitch to voters on Election DayTrump makes his last pitch to voters on Election DayTrump makes his last pitch to voters on Election DayDisney expected to lay off thousands in its biggest round of cuts this yearDisney expected to lay off thousands in its biggest round of cuts this yearDisney expected to lay off thousands in its biggest round of cuts this yearAckman warns speculative trading is turning the stock market into a casinoAckman warns speculative trading is turning the stock market into a casinoAckman warns speculative trading is turning the stock market into a casinoRedMagic takes its RGB liquid-cooled gaming phone global as the 12 ProRedMagic takes its RGB liquid-cooled gaming phone global as the 12 ProRedMagic takes its RGB liquid-cooled gaming phone global as the 12 ProMalachi Jordan commits to St. John's, its first five-star recruit in 13 yearsMalachi Jordan commits to St. John's, its first five-star recruit in 13 yearsMalachi Jordan commits to St. John's, its first five-star recruit in 13 yearsSigns point to a big BioWare N7 Day celebration planned before the studio closedSigns point to a big BioWare N7 Day celebration planned before the studio closedSigns point to a big BioWare N7 Day celebration planned before the studio closedCritics of Ilhan Omar describe threats and intimidation, report saysCritics of Ilhan Omar describe threats and intimidation, report saysCritics of Ilhan Omar describe threats and intimidation, report saysGoogle app may replace its bottom bar tabs with Videos, Images and YouGoogle app may replace its bottom bar tabs with Videos, Images and YouGoogle app may replace its bottom bar tabs with Videos, Images and YouStar Wars Jedi: Survivor's final hidden secret found after three and a half yearsStar Wars Jedi: Survivor's final hidden secret found after three and a half yearsStar Wars Jedi: Survivor's final hidden secret found after three and a half yearsWar widens in the Black Sea, testing NATO's red linesWar widens in the Black Sea, testing NATO's red linesWar widens in the Black Sea, testing NATO's red linesGoogle confirms Android Family Hub, a new family space inside SettingsGoogle confirms Android Family Hub, a new family space inside SettingsGoogle confirms Android Family Hub, a new family space inside SettingsFive rescued off Kiribati after three months adrift at sea, four still missingFive rescued off Kiribati after three months adrift at sea, four still missingFive rescued off Kiribati after three months adrift at sea, four still missingDeath toll reaches 31 after Russian strikes hit a Ukrainian aid siteDeath toll reaches 31 after Russian strikes hit a Ukrainian aid siteDeath toll reaches 31 after Russian strikes hit a Ukrainian aid siteKing calls the slave trade a shameful chapter in Commonwealth addressKing calls the slave trade a shameful chapter in Commonwealth addressKing calls the slave trade a shameful chapter in Commonwealth addressScientists spot a potentially massive dwarf planet candidate beyond PlutoScientists spot a potentially massive dwarf planet candidate beyond PlutoScientists spot a potentially massive dwarf planet candidate beyond PlutoEating blueberries every day may ease depressive symptoms in older adultsEating blueberries every day may ease depressive symptoms in older adultsEating blueberries every day may ease depressive symptoms in older adultsIran warns of a 'new battlefield' after reported US strike on QeshmIran warns of a 'new battlefield' after reported US strike on QeshmIran warns of a 'new battlefield' after reported US strike on QeshmAnthropic's compute costs eat a bigger share of revenue as growth surgesAnthropic's compute costs eat a bigger share of revenue as growth surgesAnthropic's compute costs eat a bigger share of revenue as growth surgesStartup plans 50,000 space mirrors to beam sunlight down at nightStartup plans 50,000 space mirrors to beam sunlight down at nightStartup plans 50,000 space mirrors to beam sunlight down at nightChina steps up Middle East diplomacy as fears grow of a renewed US-Iran warChina steps up Middle East diplomacy as fears grow of a renewed US-Iran warChina steps up Middle East diplomacy as fears grow of a renewed US-Iran warTrump makes his last pitch to voters on Election DayTrump makes his last pitch to voters on Election DayTrump makes his last pitch to voters on Election DayDisney expected to lay off thousands in its biggest round of cuts this yearDisney expected to lay off thousands in its biggest round of cuts this yearDisney expected to lay off thousands in its biggest round of cuts this yearAckman warns speculative trading is turning the stock market into a casinoAckman warns speculative trading is turning the stock market into a casinoAckman warns speculative trading is turning the stock market into a casinoRedMagic takes its RGB liquid-cooled gaming phone global as the 12 ProRedMagic takes its RGB liquid-cooled gaming phone global as the 12 ProRedMagic takes its RGB liquid-cooled gaming phone global as the 12 ProMalachi Jordan commits to St. John's, its first five-star recruit in 13 yearsMalachi Jordan commits to St. John's, its first five-star recruit in 13 yearsMalachi Jordan commits to St. John's, its first five-star recruit in 13 yearsSigns point to a big BioWare N7 Day celebration planned before the studio closedSigns point to a big BioWare N7 Day celebration planned before the studio closedSigns point to a big BioWare N7 Day celebration planned before the studio closedCritics of Ilhan Omar describe threats and intimidation, report saysCritics of Ilhan Omar describe threats and intimidation, report saysCritics of Ilhan Omar describe threats and intimidation, report saysGoogle app may replace its bottom bar tabs with Videos, Images and YouGoogle app may replace its bottom bar tabs with Videos, Images and YouGoogle app may replace its bottom bar tabs with Videos, Images and YouStar Wars Jedi: Survivor's final hidden secret found after three and a half yearsStar Wars Jedi: Survivor's final hidden secret found after three and a half yearsStar Wars Jedi: Survivor's final hidden secret found after three and a half yearsWar widens in the Black Sea, testing NATO's red linesWar widens in the Black Sea, testing NATO's red linesWar widens in the Black Sea, testing NATO's red linesGoogle confirms Android Family Hub, a new family space inside SettingsGoogle confirms Android Family Hub, a new family space inside SettingsGoogle confirms Android Family Hub, a new family space inside SettingsFive rescued off Kiribati after three months adrift at sea, four still missingFive rescued off Kiribati after three months adrift at sea, four still missingFive rescued off Kiribati after three months adrift at sea, four still missingDeath toll reaches 31 after Russian strikes hit a Ukrainian aid siteDeath toll reaches 31 after Russian strikes hit a Ukrainian aid siteDeath toll reaches 31 after Russian strikes hit a Ukrainian aid siteKing calls the slave trade a shameful chapter in Commonwealth addressKing calls the slave trade a shameful chapter in Commonwealth addressKing calls the slave trade a shameful chapter in Commonwealth addressScientists spot a potentially massive dwarf planet candidate beyond PlutoScientists spot a potentially massive dwarf planet candidate beyond PlutoScientists spot a potentially massive dwarf planet candidate beyond PlutoEating blueberries every day may ease depressive symptoms in older adultsEating blueberries every day may ease depressive symptoms in older adultsEating blueberries every day may ease depressive symptoms in older adultsIran warns of a 'new battlefield' after reported US strike on QeshmIran warns of a 'new battlefield' after reported US strike on QeshmIran warns of a 'new battlefield' after reported US strike on Qeshm
Advertisement
Text size:
Global • 2026-10-30, 14:37 GMT • ~1 min read

First patient gets pioneering stem-cell treatment for Parkinson's

پارکنسنز کے لیے پہلے مریض کو جدید اسٹیم سیل علاج دیا گیا

पार्किंसन के लिए पहले मरीज़ को अग्रणी स्टेम सेल इलाज दिया गया

First patient gets pioneering stem-cell treatment for Parkinson's

Key points

اہم نکات

मुख्य बातें

  • A patient has undergone a pioneering stem-cell therapy for Parkinson's disease in a world-first, Japanese drugmaker Sumitomo Pharma said on Friday.
  • The treatment involves transplanting millions of induced pluripotent stem cells, which can develop into any cell in the body, into the patient's brain.
  • Japanese regulators gave the therapy conditional approval in March after a successful clinical trial, and the first transplant was performed at Kyoto University Hospital in October.
  • جاپانی دوا ساز کمپنی سومیتومو فارما نے جمعہ کو بتایا کہ پارکنسنز کی بیماری کے لیے دنیا میں پہلی بار ایک مریض کو جدید اسٹیم سیل تھراپی دی گئی ہے۔ اس علاج میں لاکھوں انڈیوسڈ پلوری پوٹینٹ اسٹیم سیلز مریض کے دماغ میں منتقل کیے جاتے ہیں، جو جسم کے کسی بھی سیل میں تبدیل ہو سکتے ہیں۔ جاپانی ریگولیٹرز نے کامیاب کلینیکل ٹرائل کے بعد مارچ میں اس تھراپی کی مشروط منظوری دی تھی، اور پہلا ٹرانسپلانٹ اکتوبر میں کیوٹو یونیورسٹی اسپتال میں کیا گیا۔ ٹرائل میں 50 سے 69 سال کے سات مریضوں کو امپلانٹ لگائے گئے، دو سال تک نگرانی میں کوئی بڑا مضر اثر نہیں ملا، اور چار مریضوں کی علامات میں بہتری آئی۔ کمپنی کا ارادہ ہے کہ مارچ 2029 تک 20 سے 30 مریضوں کو ٹرانسپلانٹ دیا جائے۔
  • जापानी दवा कंपनी सुमितोमो फार्मा ने शुक्रवार को बताया कि पार्किंसन रोग के लिए दुनिया में पहली बार एक मरीज़ को अग्रणी स्टेम सेल थेरेपी दी गई है। इस इलाज में लाखों इंड्यूस्ड प्लुरिपोटेंट स्टेम सेल मरीज़ के दिमाग में प्रत्यारोपित किए जाते हैं, जो शरीर की किसी भी कोशिका में बदल सकते हैं। जापानी नियामकों ने सफल क्लीनिकल परीक्षण के बाद मार्च में इस थेरेपी को सशर्त मंज़ूरी दी थी, और पहला प्रत्यारोपण अक्टूबर में क्योटो विश्वविद्यालय अस्पताल में किया गया। परीक्षण में 50 से 69 वर्ष के सात मरीज़ों को इम्प्लांट लगाए गए, दो साल की निगरानी में कोई बड़ा दुष्प्रभाव नहीं मिला, और चार मरीज़ों के लक्षणों में सुधार हुआ। कंपनी की योजना मार्च 2029 तक 20 से 30 मरीज़ों को प्रत्यारोपण देने की है।

A patient has undergone a pioneering stem-cell therapy for Parkinson's disease in a world-first, Japanese drugmaker Sumitomo Pharma said on Friday. The treatment involves transplanting millions of induced pluripotent stem cells, which can develop into any cell in the body, into the patient's brain. Japanese regulators gave the therapy conditional approval in March after a successful clinical trial, and the first transplant was performed at Kyoto University Hospital in October. In the trial, seven patients aged 50 to 69 received implants, were monitored for two years with no major adverse effects, and four showed improved symptoms. The company plans transplants for 20 to 30 patients by March 2029.

جاپانی دوا ساز کمپنی سومیتومو فارما نے جمعہ کو بتایا کہ پارکنسنز کی بیماری کے لیے دنیا میں پہلی بار ایک مریض کو جدید اسٹیم سیل تھراپی دی گئی ہے۔ اس علاج میں لاکھوں انڈیوسڈ پلوری پوٹینٹ اسٹیم سیلز مریض کے دماغ میں منتقل کیے جاتے ہیں، جو جسم کے کسی بھی سیل میں تبدیل ہو سکتے ہیں۔ جاپانی ریگولیٹرز نے کامیاب کلینیکل ٹرائل کے بعد مارچ میں اس تھراپی کی مشروط منظوری دی تھی، اور پہلا ٹرانسپلانٹ اکتوبر میں کیوٹو یونیورسٹی اسپتال میں کیا گیا۔ ٹرائل میں 50 سے 69 سال کے سات مریضوں کو امپلانٹ لگائے گئے، دو سال تک نگرانی میں کوئی بڑا مضر اثر نہیں ملا، اور چار مریضوں کی علامات میں بہتری آئی۔ کمپنی کا ارادہ ہے کہ مارچ 2029 تک 20 سے 30 مریضوں کو ٹرانسپلانٹ دیا جائے۔

जापानी दवा कंपनी सुमितोमो फार्मा ने शुक्रवार को बताया कि पार्किंसन रोग के लिए दुनिया में पहली बार एक मरीज़ को अग्रणी स्टेम सेल थेरेपी दी गई है। इस इलाज में लाखों इंड्यूस्ड प्लुरिपोटेंट स्टेम सेल मरीज़ के दिमाग में प्रत्यारोपित किए जाते हैं, जो शरीर की किसी भी कोशिका में बदल सकते हैं। जापानी नियामकों ने सफल क्लीनिकल परीक्षण के बाद मार्च में इस थेरेपी को सशर्त मंज़ूरी दी थी, और पहला प्रत्यारोपण अक्टूबर में क्योटो विश्वविद्यालय अस्पताल में किया गया। परीक्षण में 50 से 69 वर्ष के सात मरीज़ों को इम्प्लांट लगाए गए, दो साल की निगरानी में कोई बड़ा दुष्प्रभाव नहीं मिला, और चार मरीज़ों के लक्षणों में सुधार हुआ। कंपनी की योजना मार्च 2029 तक 20 से 30 मरीज़ों को प्रत्यारोपण देने की है।

Read Full News → Back to all news

Related stories

متعلقہ خبریں

संबंधित खबरें

Most read

سب سے زیادہ پڑھی گئی

सबसे ज़्यादा पढ़ी गई

  1. Loading...
Advertisement